Novartis AG (NYSE:NVS)

92.49
Delayed Data
As of Jun 21
 +0.12 / +0.13%
Today’s Change
64.76
Today|||52-Week Range
93.34
+20.33%
Year-to-Date
3 Drugs Under FDA Review With Blockbuster Potential
Jun 20 / MotleyFool.comFOO - Paid Partner Content
Novartis (NVS) Announces Promising Data on Tasigna & Hyrimoz
Jun 17 / Zacks.comZAK - Paid Partner Content
Jazz's (JAZZ) New Sleep Drug Sunosi Gets Schedule IV Status
Jun 18 / Zacks.comZAK - Paid Partner Content
Roche Reports Positive Data on Rituxan for Pemphigus Vulgaris
Jun 13 / Zacks.comZAK - Paid Partner Content
Roche's Rozlytrek Gets Approval in Japan for Solid Tumors
Jun 18 / Zacks.comZAK - Paid Partner Content
Top Analyst Reports for Visa, Netflix & Accenture
Jun 13 / Zacks.comZAK - Paid Partner Content
3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal
Jun 18 / MotleyFool.comFOO - Paid Partner Content
Ligand Inks Oncology Drug Discovery Deal With PhoreMost
Jun 13 / Zacks.comZAK - Paid Partner Content
J&J's (JNJ) Tremfya Meets Goal in Psoriatic Arthritis Study
Jun 17 / Zacks.comZAK - Paid Partner Content
Roche's Rituxan Gets Priority Review for Blood Disorder
Jun 12 / Zacks.comZAK - Paid Partner Content

Today’s Trading

Previous close92.37
Today’s open92.56
Day’s range91.76 - 92.69
Volume2,316,338
Average volume (3 months)2,368,616
Market cap$212.7B
Data as of 4:02pm ET, 06/21/2019

Growth & Valuation

Earnings growth (last year)+65.34%
Earnings growth (this year)+6.80%
Earnings growth (next 5 years)+7.70%
Revenue growth (last year)+5.41%
P/E ratio17.3
Price/Sales3.87
Price/Book2.72

Competitors

 Today’s
change
Today’s
% change
MRKMerck-0.03-0.04%
PFEPfizer+0.07+0.16%
ABTAbbott Laboratories+0.06+0.07%
ABBVAbbVie+0.44+0.56%
Data as of 4:04pm ET, 06/21/2019

Financials

Next reporting dateJuly 18, 2019
EPS forecast (this quarter)$1.22
Annual revenue (last year)$52.0B
Annual profit (last year)$12.6B
Net profit margin24.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Vasant Narasimhan
Chief Financial Officer
Harry Werner Kirsch
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts